GL1X · GenesisL1 explorer

Research workbench

X-ray crystal structure of human BRD4(D1) in complex with 2-(4-{5-[6- (2,5-DIBROMOPHENOXY)PYRIDIN-2-yl]-4-methyl-1H-1,2,3-triazol-1- YL}PIPERIDIN-1-yl)-N,N-dimethylethan-1-amine (compound 26)

Analyse X-ray crystal structure of human BRD4(D1) in complex with 2-(4-{5-[6… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7MLQ
Type
protein
Length
126 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bromodomain-containing protein 4
UniProt
O60885
Ligands
ZHV, CL
Pockets
1 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABromodomain-containing protein 4protein12652% helix, 0% strandO60885

Ligands and binding sites

  • ZHV · 2-(4-{5-[6-(2,5-dibromophenoxy)pyridin-2-yl]-4-methyl-1H-1,2,3-triazol-1-yl}piperidin-1-yl)-N,N-dimethylethan-1-amine · ligand · chains A
  • CL · Chloride ion · ion · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11370.560.8226ZHV

Compared structures

  • 7MLQ · X-ray crystal structure of human BRD4(D1) in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • O60885 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 4 (O60885) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.